secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001837607-25-000072
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma raises $6M private placement, plans Daewoong note exchange for ~23M shares
--------------------------------------------------------------------------------

- First closing of private placement expected week of Nov 17, 2025: 1,964,905 shares/pre-funded warrants at $0.9116 per share.
- Second closing subject to stockholder approval: 4,616,924 shares and 6,581,829 warrants at $1.09392.
- Term sheet with Daewoong to exchange existing notes for $1.5M new note, ~23.1M shares, and 8M warrants.
- True-Up Warrants issued to maintain investor ownership percentage post-Daewoong exchange.
- Investors receive registration rights for resale of shares and warrant shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000072/0001837607-25-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000072/aeon-20251112x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-25-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer